ASH 2012: Dr Kipps Interview Part 3 on genetic... - CLL Support

CLL Support

23,339 members40,047 posts

ASH 2012: Dr Kipps Interview Part 3 on genetics, epigenetics, and new and old CLL therapies

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

Dr. Kipps makes complex science accessible as he reviews the new understanding of CLL and how they translate into new therapies and repurposing of old therapies. See bkoffman,blogspot.com for the third part of the ASH 2012 interview.

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"

Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...
AussieNeil profile image
Partner

ASH 2016: Dr. Seymour on Combination therapies with venetoclax

Hi, I am a big believer in combination therapies for CLL. This week I'm posting an interview on our...
bkoffman profile image
CLL CURE Hero

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

Venetoclax was changed how we treat CLL, but it doesn't work for everyone and it doesn't always...
bkoffman profile image
CLL CURE Hero

OncLive 9 CLL Videos - Optimizing the Treatment of CLL With Novel Therapies and more Take-home messages from ASH 2021

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for...
lankisterguy profile image
Volunteer

ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib

ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...
bkoffman profile image
CLL CURE Hero